Premier CRO in Fort Collins, CO service offerings. Contact us today for more information at 970-493-0118

1. Your Partner for Co-Innovation
1

2. 2

3. We have the experience you need!
3
Unparalleled Regulatory Guidance >> to ensure unhindered FDA/EPA/OECD acceptance
Specialized Expertise & Facilities >> to conduct studies effectively
Small & Large Animal Species>> to customize studies & meet unique needs
Depth of Experience >> to conduct studies efficiently and humanely
Responsive Updates & Feedback >> to provide guidance for mid-course adjustments
We treat your project like it’s our own

4. Comprehensive guidance from start to finish
4
Experienced study
directors involved
throughout
Expert protocol
development process
Accelerated IACUC
Approval
Able to meet aggressive
timelines
Large library of
standard studies
Standardized reporting
methods
Continuous study
progress updates
Experienced
Regulatory Review

5. CAPABILITIES
Diverse Customized Studies
5

6. Well-rounded experience we can leverage
 Over 150 years of combined experience conducting
toxicology studies
 Distinguished IACUC Committee involvement (to
deliberate and approve projects on ongoing basis)
 Track Record of Receiving Approval for Several IND &
NDA Enabling Studies
6

7. Wide range of capabilities
■ PK/MTD to DART studies
■ Custom Medical Device preclinical studies
■ 510K to IND/IDE submission regulatory guidance
■ IND/NDA Enabling studies
■ Multi-functional capabilities spanning in vivo models, surgeries, clinical
and histopathology
7

8. Capabilities (cont.)
 Behavioral Evaluation: FOB Analyses &
Maze Testing
 Modern, fully-equipped veterinary
surgical suite
 Imaging Equipment CT Scanner, C-ARM &
Dexascan
 24/7 Video Monitoring
8

9. OUR ANIMALS
Diverse Animal Species From Small to Large
9

10. Outdoor Pastures - Large Farm Animals, Equine to Swine
Indoor Facilities – Rodents to Dogs
10

11. Species of focus (GLP & non-GLP)
 Acute to chronic toxicity
 Pharmacokinetic / Toxicokinetic
models
 Reproductive/ developmental
toxicology
 Special models (arthritis,
respiratory, in-vivo
biocompatibility)
 Ocular Implants
 Dermal sensitivity
 Acute/chronic toxicity
 Pharmacokinetic / Toxicokinetic
models
 Surgical device development
 Feed/nutrition
 Wound Healing
11
 Acute to chronic toxicity
 Pharmacokinetic / Toxicokinetic
models
 Surgical models
 Gait analysis
 Efficacy
 MTD
SMALL LARGE
S
t
u
d
y
T
y
p
e
s
Mice, rats, ferrets, rabbits, hamsters,
guinea pigs, etc.
Dogs, cats, horses, etc. Porcine, Equine, Bovine, Ovine, Poultry, etc.

12. Case studies -- Devices
■ Pulmonary Devices to Treat Emphysema
■ Tissue Adhesives & Wound Healing
■ Cardio-Vascular Stents
■ Surgical Devices Development
■ Ocular Implants
■ Muscular Implants
■ Ablation Devices (Liver, Lung, Bladder)

13. Case studies - Drugs
■ Neurotropic Drug – DART/NDA Enabling, allowed Phase-3 Clinical
Trials
■ Ophthalmic Biologic- Resulted in Approval of Phase-2 Clinical Trials
with Minimal Testing
■ Nasal Delivery
■ Ocular Drug Delivery
■ IBD Models
■ 5 Different Drugs for Separate Clients Taken off Clinical Hold
13

14. CSU Department of Lab Animal Resources
 CARE & CSU LAR Relationship
 Interinstitutional Agreements
 World Class Veterinary Expertise/Collaboration
 Shared IACUC members reduce regulatory delays
14

15. Certifications
AAALAC Certified
USDA licensed
OLAW assured
EU ETS123
15

16. Let us co-innovate with you!
CEO/CSO
 Rajan Bawa, PhD CEO/CSO
 (970) 493-0118
 rbawa@careresearchllc.com
National Sales Manager
 Brandy Phillips
 970-493-0118
 bphillips@careresearchllc.com